M
Mabpharm Ltd
HKEX:2181
Mabpharm Ltd
HKEX:2181
Price:
0.55
HKD
-1.79%
Market Cap:
HK$2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mabpharm Ltd
HKEX:2181
|
CN |
|
NK Russneft' PAO
MOEX:RNFT
|
RU |
|
Rishi Techtex Ltd
BSE:523021
|
IN |
|
S
|
Sino Golf Holdings Ltd
HKEX:361
|
HK |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
|
W
|
Welbilt Inc
F:6M6
|
US |
|
O
|
Origin Enterprises PLC
ISEQ:OIZ
|
IE |
|
US Nuclear Corp
OTC:UCLE
|
US |
|
C
|
China Sanjiang Fine Chemicals Co Ltd
HKEX:2198
|
CN |
|
Rogers Communications Inc
TSX:RCI.B
|
CA |
|
J
|
Jiangsu Maysta Chemical Co Ltd
SSE:603041
|
CN |
|
M
|
Msg Life Ag
XHAM:MSGL
|
DE |
Multiples-Based Value
The Multiples-Based Value of one Mabpharm Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.55 HKD, Mabpharm Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Mabpharm Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Mabpharm Ltd Competitors
Mabpharm Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
M
|
Mabpharm Ltd
HKEX:2181
|
2.3B HKD | 4.7 | -72.6 | 48.4 | -124.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
